| 1 |
27003101 | Interrogating the Role of Receptor-Mediated Mechanisms: Biological Fate of Peptide-Functionalized Radiolabeled Gold Nanoparticles in Tumor Mice. | 2016 Apr 20 |
1 |
| 2 |
25459113 | Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy. | 2015 Feb |
1 |
| 3 |
25479439 | Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models. | 2015 Feb |
1 |
| 4 |
23708872 | 177Lu-labeled RGD-BBN heterodimeric peptide for targeting prostate carcinoma. | 2013 Sep |
2 |
| 5 |
24094035 | Tumor diagnosis with new 111In-radioligands based on truncated human gastrin releasing peptide sequences: synthesis and preclinical comparison. | 2013 Nov 14 |
2 |
| 6 |
17262215 | DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours. | 2007 Aug |
2 |
| 7 |
15653666 | (68)Ga-labeled peptides in tumor imaging. | 2005 Jan |
1 |
| 8 |
20641835 | 64Cu-DOTA-[Pro1,Tyr4]-Bombesin[1-14] | 2004 |
5 |
| 9 |
12862428 | MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue. | 2003 Jul-Aug |
1 |